Indication
E. coli pelvic inflammatory disease
*Escherichia coli* pelvic inflammatory disease is an upper female genital tract infection caused by ascending invasion of the Gram-negative enteric bacterium *Escherichia coli*, either as a primary pathogen or as part of a complex polymicrobial process. Read more about E. coli pelvic inflammatory disease
93 drugs 47 manufacturers
Drugs that treat it
Common E. coli pelvic inflammatory disease therapies.
ZOSYN IN DEXTROSE (ISO-OSM) (piperacillin and tazobactam in dextrose, iso-osmotic)
CEFOTAN (cefotetan disodium)
ZOSYN (piperacillin and tazobactam in dextrose, iso-osmotic)
CEFOTAXIME SODIUM
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Escherichia coli* pelvic inflammatory disease is an upper female genital tract infection caused by ascending invasion of the Gram-negative enteric bacterium *Escherichia coli*, either as a primary pathogen or as part of a complex polymicrobial process.
The condition primarily affects reproductive-age females and involves inflammatory changes across anatomical structures including the endometrium, fallopian tubes, ovaries, and adjacent pelvic peritoneum.
Clinically, it is characterized by lower abdominal or pelvic pain, uterine and adnexal tenderness, cervical motion tenderness, purulent vaginal discharge, and systemically elevated inflammatory markers or fever.
Pathophysiologically, non-sexually transmitted enteric bacteria like *E.
coli* ascend through the cervix, promoting mucosal inflammation and tissue damage that can progress to pyosalpinx, tubo-ovarian abscess, long-term tubal scarring, ectopic pregnancy, or chronic pelvic pain.
- nih.gov
*Escherichia coli* pelvic inflammatory disease is an upper female genital tract infection caused by ascending invasion of the Gram-negative enteric bacterium *Escherichia coli*, either as a primary pathogen or as part of a complex polymicrobial process The condition primarily affects reproductive-age females and involves inflammatory changes across anatomical structures including the endometrium, fallopian tubes, ovaries, and adjacent pelvic peritoneum Clinically, it is characterized by lower ab...
- cdc.gov
Clinically, it is characterized by lower abdominal or pelvic pain, uterine and adnexal tenderness, cervical motion tenderness, purulent vaginal discharge, and systemically elevated inflammatory markers or fever
Personalize your experience
Follow E. coli pelvic inflammatory disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.